| Medical and Health Sciences | 2021-2025 | 749 | US 258 | 99.83 |
| Rheumatology | Lifetime | 345 | US 153 | 98.55 |
| Rheumatology | 2021-2025 | 38 | US 11 | 99.32 |
| Epidemiology | 2021-2025 | 206 | US 69 | 98.53 |
| Infectious Diseases | 2021-2025 | 414 | US 167 | 91.74 |
| Immunology | 2021-2025 | 535 | US 195 | 84.99 |
| Hematology | 2021-2025 | 365 | US 169 | 80.43 |
| Psychiatry and Mental health | 2021-2025 | 861 | US 349 | 62.38 |
| COVID-19 Clinical Research Studies | Lifetime | 570 | US 138 | 97.89 |
| Spondyloarthritis Studies and Treatments | Lifetime | 93 | US 24 | 98.90 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 326 | US 94 | 98.61 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 230 | US 77 | 98.47 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 117 | US 53 | 98.22 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 238 | US 77 | 98.01 |
| COVID-19 and healthcare impacts | Lifetime | 715 | US 253 | 93.22 |
| Long-Term Effects of COVID-19 | Lifetime | 991 | US 216 | 94.17 |
| Bone and Joint Diseases | Lifetime | 525 | US 207 | 96.12 |
| Muscle and Compartmental Disorders | Lifetime | 291 | US 124 | 94.52 |
| Eosinophilic Disorders and Syndromes | Lifetime | 808 | US 325 | 94.72 |
| Dermatological and COVID-19 studies | Lifetime | 244 | US 67 | 89.54 |
| Musculoskeletal Disorders and Rehabilitation | Lifetime | 775 | US 337 | 84.46 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 758 | US 222 | 74.06 |
| Heterotopic Ossification and Related Conditions | Lifetime | 613 | US 248 | 71.12 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 10 | US 6 | 99.30 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 40 | US 12 | 99.01 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 21 | US 7 | 99.13 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 51 | US 15 | 98.42 |
| Bone and Joint Diseases | 2021-2025 | 53 | US 8 | 95.22 |
| COVID-19 Clinical Research Studies | 2021-2025 | 962 | US 216 | 96.16 |
| Muscle Physiology and Disorders | 2021-2025 | 121 | US 46 | 95.16 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 119 | US 25 | 97.53 |
| Long-Term Effects of COVID-19 | 2021-2025 | 932 | US 184 | 93.23 |
| COVID-19 and healthcare impacts | 2021-2025 | 662 | US 220 | 91.44 |
| Dermatological and COVID-19 studies | 2021-2025 | 49 | US 11 | 88.09 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 254 | US 112 | 89.79 |
| Skin Diseases and Diabetes | 2021-2025 | 74 | US 26 | 80.39 |
| Peripheral Neuropathies and Disorders | 2021-2025 | 537 | US 106 | 86.74 |
| Musculoskeletal Disorders and Rehabilitation | 2021-2025 | 107 | US 32 | 81.35 |
| Parkinson's Disease and Spinal Disorders | 2021-2025 | 70 | US 22 | 82.77 |
| Muscle and Compartmental Disorders | 2021-2025 | 184 | US 37 | 77.10 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | 2021-2025 | 919 | US 199 | 77.62 |
| Heterotopic Ossification and Related Conditions | 2021-2025 | 138 | US 48 | 63.27 |
| Intramuscular injections and effects | 2021-2025 | 166 | US 38 | 62.05 |
